8EZL
| Pfs25 in complex with transmission-reducing antibody AS01-50 | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 25 kDa ookinete surface antigen, Transmission-reducing antibody AS01-50, ... | Authors: | Shukla, N, Tang, W.K, Tolia, N.H. | Deposit date: | 2022-11-01 | Release date: | 2023-08-16 | Last modified: | 2024-10-16 | Method: | X-RAY DIFFRACTION (2.3 Å) | Cite: | A human antibody epitope map of the malaria vaccine antigen Pfs25. Npj Vaccines, 8, 2023
|
|
8EZM
| Pfs25 in complex with transmission-reducing antibody AS01-63 | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 25 kDa ookinete surface antigen, SULFATE ION, ... | Authors: | Shukla, N, Tang, W.K, Tolia, N.H. | Deposit date: | 2022-11-01 | Release date: | 2023-08-16 | Method: | X-RAY DIFFRACTION (2.1 Å) | Cite: | A human antibody epitope map of the malaria vaccine antigen Pfs25. Npj Vaccines, 8, 2023
|
|
8EZK
| |
8GIE
| |
8GIF
| |
8GID
| |
6O38
| Structure of a chaperone-substrate complex | Descriptor: | Acinetobacter secreted protease CpaA, SULFATE ION, Type II secretion chaperone CpaB, ... | Authors: | Urusova, D.V, Tolia, N.H. | Deposit date: | 2019-02-26 | Release date: | 2019-07-24 | Last modified: | 2024-10-16 | Method: | X-RAY DIFFRACTION (2.595 Å) | Cite: | The structure ofAcinetobacter-secreted protease CpaA complexed with its chaperone CpaB reveals a novel mode of a T2SS chaperone-substrate interaction. J.Biol.Chem., 294, 2019
|
|
6OAN
| Structure of DBP in complex with human neutralizing antibody 053054 | Descriptor: | Antibody 053054 single chain variable fragment, Duffy binding surface protein region II, SULFATE ION | Authors: | Urusova, D, Tolia, N.H. | Deposit date: | 2019-03-18 | Release date: | 2019-06-12 | Last modified: | 2023-10-11 | Method: | X-RAY DIFFRACTION (2.9 Å) | Cite: | Structural basis for neutralization of Plasmodium vivax by naturally acquired human antibodies that target DBP. Nat Microbiol, 4, 2019
|
|
6OAO
| Structure of DBP in complex with human neutralizing antibody 092096 | Descriptor: | Antibody 092096 single chain variable fragment, Duffy binding surface protein region II, SULFATE ION | Authors: | Urusova, D, Tolia, N.H. | Deposit date: | 2019-03-18 | Release date: | 2019-06-12 | Last modified: | 2023-10-11 | Method: | X-RAY DIFFRACTION (3.497 Å) | Cite: | Structural basis for neutralization of Plasmodium vivax by naturally acquired human antibodies that target DBP. Nat Microbiol, 4, 2019
|
|
4YFS
| |
4ZEV
| Crystal structure of PfHAD1 in complex with mannose-6-phosphate | Descriptor: | 6-O-phosphono-alpha-D-mannopyranose, MAGNESIUM ION, PHOSPHATE ION, ... | Authors: | Park, J, Tolia, N.H. | Deposit date: | 2015-04-20 | Release date: | 2015-09-09 | Last modified: | 2023-09-27 | Method: | X-RAY DIFFRACTION (1.8 Å) | Cite: | Cap-domain closure enables diverse substrate recognition by the C2-type haloacid dehalogenase-like sugar phosphatase Plasmodium falciparum HAD1. Acta Crystallogr. D Biol. Crystallogr., 71, 2015
|
|
4ZEW
| Crystal structure of PfHAD1 in complex with glucose-6-phosphate | Descriptor: | 6-O-phosphono-alpha-D-glucopyranose, MAGNESIUM ION, PHOSPHATE ION, ... | Authors: | Park, J, Tolia, N.H. | Deposit date: | 2015-04-20 | Release date: | 2015-09-09 | Last modified: | 2023-09-27 | Method: | X-RAY DIFFRACTION (1.9 Å) | Cite: | Cap-domain closure enables diverse substrate recognition by the C2-type haloacid dehalogenase-like sugar phosphatase Plasmodium falciparum HAD1. Acta Crystallogr. D Biol. Crystallogr., 71, 2015
|
|
4ZEX
| Crystal structure of PfHAD1 in complex with glyceraldehyde-3-phosphate | Descriptor: | GLYCERALDEHYDE-3-PHOSPHATE, MAGNESIUM ION, PHOSPHATE ION, ... | Authors: | Park, J, Tolia, N.H. | Deposit date: | 2015-04-20 | Release date: | 2015-09-09 | Last modified: | 2023-09-27 | Method: | X-RAY DIFFRACTION (2 Å) | Cite: | Cap-domain closure enables diverse substrate recognition by the C2-type haloacid dehalogenase-like sugar phosphatase Plasmodium falciparum HAD1. Acta Crystallogr. D Biol. Crystallogr., 71, 2015
|
|
1R6Z
| The Crystal Structure of the Argonaute2 PAZ domain (as a MBP fusion) | Descriptor: | Chimera of Maltose-binding periplasmic protein and Argonaute 2, NICKEL (II) ION, alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose | Authors: | Song, J.J, Liu, J, Tolia, N.H, Schneiderman, J, Smith, S.K, Martienssen, R.A, Hannon, G.J, Joshua-Tor, L. | Deposit date: | 2003-10-17 | Release date: | 2004-01-13 | Last modified: | 2023-08-23 | Method: | X-RAY DIFFRACTION (2.8 Å) | Cite: | The crystal structure of the Argonaute2 PAZ domain reveals an RNA binding motif in RNAi effector complexes. Nat.Struct.Biol., 10, 2003
|
|
4GF2
| Crystal structure of Plasmodium falciparum Erythrocyte Binding Antigen 140 (PfEBA-140/BAEBL) | Descriptor: | Erythrocyte binding antigen 140, GLYCEROL | Authors: | Lin, D.H, Malpede, B.M, Batchelor, J.D, Tolia, N.H. | Deposit date: | 2012-08-02 | Release date: | 2012-09-26 | Last modified: | 2023-09-13 | Method: | X-RAY DIFFRACTION (2.4 Å) | Cite: | Crystal and Solution Structures of Plasmodium falciparum Erythrocyte-binding Antigen 140 Reveal Determinants of Receptor Specificity during Erythrocyte Invasion. J.Biol.Chem., 287, 2012
|
|
1Z26
| Structure of Pyrococcus furiosus Argonaute with bound tungstate | Descriptor: | Argonaute, TUNGSTATE(VI)ION | Authors: | Rivas, F.V, Tolia, N.H, Song, J.J, Aragon, J.P, Liu, J, Hannon, G.J, Joshua-Tor, L. | Deposit date: | 2005-03-07 | Release date: | 2005-04-05 | Last modified: | 2024-02-14 | Method: | X-RAY DIFFRACTION (2.5 Å) | Cite: | Purified Argonaute2 and an siRNA form recombinant human RISC. Nat.Struct.Mol.Biol., 12, 2005
|
|
1Z25
| Structure of P.furiosus Argonaute with bound Mn2+ | Descriptor: | Argonaute, MANGANESE (II) ION | Authors: | Rivas, F.V, Tolia, N.H, Song, J.J, Aragon, J.P, Liu, J, Hannon, G.J, Joshua-Tor, L. | Deposit date: | 2005-03-07 | Release date: | 2005-04-05 | Last modified: | 2024-02-14 | Method: | X-RAY DIFFRACTION (2.7 Å) | Cite: | Purified Argonaute2 and an siRNA form recombinant human RISC. Nat.Struct.Mol.Biol., 12, 2005
|
|
7UFW
| Pfs230 D1D2 in complex with LMIV230-01 | Descriptor: | Gametocyte surface protein P230, LMIV230-01 | Authors: | Tang, W.K, Tolia, N.H. | Deposit date: | 2022-03-23 | Release date: | 2023-02-15 | Last modified: | 2024-10-09 | Method: | X-RAY DIFFRACTION (2.1 Å) | Cite: | A human antibody epitope map of Pfs230D1 derived from analysis of individuals vaccinated with a malaria transmission-blocking vaccine. Immunity, 56, 2023
|
|
7UA8
| Pfs230 D1 domain in complex with 230AL-20 | Descriptor: | 230Al-20, Gametocyte surface protein P230 | Authors: | Tang, W.K, Tolia, N.H. | Deposit date: | 2022-03-11 | Release date: | 2023-02-15 | Last modified: | 2023-10-25 | Method: | X-RAY DIFFRACTION (2.8 Å) | Cite: | A human antibody epitope map of Pfs230D1 derived from analysis of individuals vaccinated with a malaria transmission-blocking vaccine. Immunity, 56, 2023
|
|
7UA2
| Pfs230 D1 domain in complex with 230AL-18 | Descriptor: | 230AL-18, Gametocyte surface protein P230, LMIV230-01 | Authors: | Tang, W.K, Tolia, N.H. | Deposit date: | 2022-03-11 | Release date: | 2023-02-15 | Last modified: | 2023-10-25 | Method: | X-RAY DIFFRACTION (2.19 Å) | Cite: | A human antibody epitope map of Pfs230D1 derived from analysis of individuals vaccinated with a malaria transmission-blocking vaccine. Immunity, 56, 2023
|
|
7UCQ
| Pfs230 D1 domain in complex with 230AS-18 | Descriptor: | 230AS-18, Gametocyte surface protein P230 | Authors: | Tang, W.K, Tolia, N.H. | Deposit date: | 2022-03-17 | Release date: | 2023-02-15 | Last modified: | 2023-10-25 | Method: | X-RAY DIFFRACTION (2.5 Å) | Cite: | A human antibody epitope map of Pfs230D1 derived from analysis of individuals vaccinated with a malaria transmission-blocking vaccine. Immunity, 56, 2023
|
|
7UI1
| Pfs230 D1D2 domain in complex with 230AL-37 | Descriptor: | 230AL-37, Gametocyte surface protein P230, SULFATE ION | Authors: | Tang, W.K, Tolia, N.H. | Deposit date: | 2022-03-28 | Release date: | 2023-02-15 | Last modified: | 2023-10-25 | Method: | X-RAY DIFFRACTION (3.3 Å) | Cite: | A human antibody epitope map of Pfs230D1 derived from analysis of individuals vaccinated with a malaria transmission-blocking vaccine. Immunity, 56, 2023
|
|
7UC8
| Pfs230 D1 domain in complex with 230AS-73 | Descriptor: | 230AS-73, Gametocyte surface protein P230, SODIUM ION | Authors: | Tang, W.K, Tolia, N.H. | Deposit date: | 2022-03-16 | Release date: | 2023-02-15 | Last modified: | 2024-10-16 | Method: | X-RAY DIFFRACTION (2.9 Å) | Cite: | A human antibody epitope map of Pfs230D1 derived from analysis of individuals vaccinated with a malaria transmission-blocking vaccine. Immunity, 56, 2023
|
|
7U9W
| Pfs230 D1 domain in complex with 230AS-88 | Descriptor: | 230AS-88, Gametocyte surface protein P230 | Authors: | Tang, W.K, Tolia, N.H. | Deposit date: | 2022-03-11 | Release date: | 2023-02-15 | Last modified: | 2023-10-25 | Method: | X-RAY DIFFRACTION (2.79 Å) | Cite: | A human antibody epitope map of Pfs230D1 derived from analysis of individuals vaccinated with a malaria transmission-blocking vaccine. Immunity, 56, 2023
|
|
7UBS
| Pfs230 D1 domain in complex with 230AS-26 | Descriptor: | 230AS-26, Gametocyte surface protein P230 | Authors: | Tang, W.K, Tolia, N.H. | Deposit date: | 2022-03-15 | Release date: | 2023-02-15 | Last modified: | 2023-10-25 | Method: | X-RAY DIFFRACTION (2.5 Å) | Cite: | A human antibody epitope map of Pfs230D1 derived from analysis of individuals vaccinated with a malaria transmission-blocking vaccine. Immunity, 56, 2023
|
|